Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Developing TLR2 angonist for the prevention of respiratory infections in the patients with preexisting lung diseases
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |